Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and raloxifene hydrochloride

cetylpyridinium chloride anhydrous has been researched along with raloxifene hydrochloride in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Draper, MW; Herrmann, F; Pavo, I; Rizzoli, R; Uebelhart, B1
Akercan, F; Akin, M; Akman, L; Duygu, H; Ozerkan, F; Ulukus, M1

Trials

2 trial(s) available for cetylpyridinium chloride anhydrous and raloxifene hydrochloride

ArticleYear
Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:9

    Topics: Aged; Amino Acids; Biomarkers; Bone Remodeling; Creatine; Cross-Over Studies; Double-Blind Method; Estradiol; Health; Humans; Male; Middle Aged; Placebos; Raloxifene Hydrochloride; Testosterone

2004
The effects of different hormone treatment on endothelial function in healthy postmenopausal women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:9

    Topics: Adult; Brachial Artery; Drug Combinations; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Health; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Ultrasonography; Vasodilation

2013